KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

PANTOZOL 40 MG TABLETS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

40 MG

 

GENERIC NAME:

PANTOPRAZOL

 

MANUFACTURER:

ALTANA PHARMA AG

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

B

 

INDICATIONS:

Esophagitis, erosive

Gastroesophageal Reflux Disease

 

SIDE EFFECTS:

Blurred vision

depression

eosinophilia

exfoliative dermatitis

hematuria

impotence

maculopapular rash

paresthesia

photophobia

Diarrhea

headache

malaise

Acne

alopecia

appetite, increased or decreased

asthenia

constipation

dizziness

dyspepsia

eructation, acid

insomnia

nausea

nervousness

pruritus

somnolence

tinnitus

tremor

urticaria

vertigo

xerostomia

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

>> Hepatic disease, chronic, current

 

ADULT DOSE:

Gastroesophageal reflux disease (treatment) - Oral, 40 milligrams (mg) per day for up to four to eight weeks. An additional four to eight-week course may be considered in patients who have not healed after four to eight weeks of treatment. [Gastroesophageal reflux disease (prophylaxis)]- Oral, 20 mg once a day in the morning. Dose can be increased to 40 mg once a day in the morning in the case of recurrence. [Ulcer, duodenal, H. pylori-associated (treatment)]- Oral, triple therapy regimens of pantoprazole 40 mg, plus clarithromycin 500 mg, plus either amoxicillin 1000 mg or metronidazole 500 mg, in which all three medications are taken two times a day for seven days. [ Ulcer, duodenal (treatment)]- Oral, 40 mgper day for up to two weeks. An additional two-week course may be considered in patients who have not healed after two weeks of treatment. [Ulcer, gastric (treatment) ]- Oral, 40 mg per day for up to four weeks. An additional four-week course may be considered in patients who have not healed after four weeks of treatment.

 

MAXIMUM ADULT DOSE:

 

PEDIATRIC DOSE:

Safety and efficacy have not been established.  

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

Gastroesophageal reflux disease (treatment) - Oral, 40 milligrams (mg) per day for up to four to eight weeks. An additional four to eight-week course may be considered in patients who have not healed after four to eight weeks of treatment. [Gastroesophageal reflux disease (prophylaxis)]- Oral, 20 mg once a day in the morning. Dose can be increased to 40 mg once a day in the morning in the case of recurrence. [Ulcer, duodenal, H. pylori-associated (treatment)]- Oral, triple therapy regimens of pantoprazole 40 mg, plus clarithromycin 500 mg, plus either amoxicillin 1000 mg or metronidazole 500 mg, in which all three medications are taken two times a day for seven days. [ Ulcer, duodenal (treatment)]- Oral, 40 mgper day for up to two weeks. An additional two-week course may be considered in patients who have not healed after two weeks of treatment. [Ulcer, gastric (treatment) ]- Oral, 40 mg per day for up to four weeks. An additional four-week course may be considered in patients who have not healed after four weeks of treatment.

 

 

PREVIOUS

  

NEXT